Skip to main content
See every side of every news story
Published loading...Updated

Pharma industry urges EU capitals to act on Trump pricing squeeze

Summary by EURACTIV
Trump’s drug pricing squeeze is raising alarm in Brussels, where officials fear Europe’s pharma overhaul won’t be enough to keep investment this side of the Atlantic

3 Articles

Center

In the US medicines cost up to 422% more: Trump blames the EU. What is really its goal and how it can cause a shortage of global supplies

·Italy
Read Full Article

16:31 Pharmaceutical giants Merck, AstraZeneca, and Sanofi are cutting or pausing British investments, partly due to dissatisfaction with low drug prices. The same debate is heating up across Europe, fueled by...

·Belgium
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

EURACTIV broke the news in Brussels, Belgium on Monday, September 15, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal